Advertisement

---

TENGION, INC.

Tengion Announces Transactions Totaling $33.6 Million to Advance its Organ Regeneration Platform™

[2013-07-01] - $15 Million Strategic Investment from Celgene Corporation and $18.6 Million Senior Secured Convertible Note Financing with New and Existing Investors


Tengion to Participate in Panel Discussion at ISSCR 11th Annual Meeting

[2013-06-12] -


Tengion Provides Business Update and Reports First Quarter 2013 Financial Results

[2013-05-15] - -- Phase 1 trial of Neo-Kidney Augment™ on track for initiation in Sweden in second quarter of 2013 and in U.S. in fourth quarter of 2013 --
-- Actively recruiting for final three patients in Neo-Urinary Conduit™ trial --


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers